Loading...
CooperCompanies announced strong Q1 2024 results with record quarterly revenues of $931.6 million, a 9% increase year-over-year. CooperVision revenue grew by 7% and CooperSurgical revenue grew by 12%. The company's non-GAAP EPS increased by 18% to $0.85.
Revenue increased 9% year-over-year to $931.6 million.
CooperVision (CVI) revenue up 7% to $621.5 million.
CooperSurgical (CSI) revenue up 12% to $310.1 million.
Non-GAAP diluted EPS of $0.85, up $0.12 or 18% from last year's first quarter.
The Company raised its fiscal year 2024 financial guidance.
Visualization of income flow from segment revenue to net income